gilead glp-1 Oral Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies it’s the perfect companion for anyone using GLP GLP-1RAs in Neuroendocrine Tumors: The

Theravance Biopharma Announces Positive Top-Line Results from Phase 2b Study of Velusetrag (TD-5108) in Patients with Gastroparesis

This difference became even more apparent, as in patients without PHLF, GLP-2 levels decreased until POD5 but remained 2.6-fold higher in patients who developed PHLF ( p = 0.006) (Fig

Based on current evidence, GLP-1RAs are not recommended as first-line therapy for type 2 diabetic patients at high risk for colorectal cancer [47]

Many patients experience persistent weight gain and insulin resistance even with adequate thyroid hormone replacement, suggesting broader metabolic disruption

The deceleration is not a failure

Hey, endometriosis isn't just period pain, and I don't just want the birth control pill